Extended Screening Costs Associated With Selecting Donors for Fecal Microbiota Transplantation for Treatment of Metabolic Syndrome-Associated Diseases

BACKGROUND: Knowledge of the impact of the gut microbiome on conditions other than Clostridium difficile infection has been rapidly increasing, and the potential usefulness of fecal microbiota transplantation (FMT) in these indications is being explored. The need to exclude donors with an increased...

Descripción completa

Detalles Bibliográficos
Autores principales: Craven, Laura J, Nair Parvathy, Seema, Tat-Ko, Justin, Burton, Jeremy P, Silverman, Michael S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730934/
https://www.ncbi.nlm.nih.gov/pubmed/29255739
http://dx.doi.org/10.1093/ofid/ofx243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730934/
https://www.ncbi.nlm.nih.gov/pubmed/29255739
http://dx.doi.org/10.1093/ofid/ofx243

Ejemplares similares